Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 135Neoplasms 37Pancreatic Neoplasms 34Stomach Neoplasms 27Colonic Neoplasms 23Neoplasm Metastasis 20Rectal Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Esophageal Neoplasms 10Cholangiocarcinoma 10Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Biliary Tract Neoplasms 8Adenocarcinoma Of Esophagus 8Ovarian Neoplasms 7Triple Negative Breast Neoplasms 6Gallbladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Gastrointestinal Neoplasms 5Digestive System Neoplasms 5Breast Neoplasms 5Advanced Solid Tumors 5Squamous Cell Carcinoma of Head and Neck 4Solid Tumors 4Melanoma 4Intestinal Neoplasms 4Carcinoma, Pancreatic Ductal 4Carcinoma, Hepatocellular 4Advanced Solid Tumor 4Small Cell Lung Carcinoma 3

Interventions

tocilizumab 1selicrelumab 1indusatumab 1cobimetinib 1atezolizumab 1Tiragolumab 1PEGPH20 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Bevacizumab 14-fluorobenzoyl-TN-14003 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pancreatic Adenocarcinoma × Leucovorin × Clear all
NCT03193190 2025-11-21

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Hoffmann-La Roche

Phase 1/2 Completed
341 enrolled 28 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡